Amorepacific Stock: Can the Fallen K-Beauty King Reclaim Its Crown? (2026 Valuation)

For two decades, Amorepacific was K-beauty. Then a younger, gadget-selling upstart called APR passed it in market value in August 2025 — and the old king now trades 28% below its own 52-week high (as of the July 28, 2026 close). But underneath a scary-looking headline earnings number, something quieter is happening: China stopped bleeding, the Americas are compounding, and operating profit rose 52% in FY2025. This is a decode of what the fallen giant is actually worth — and which of its three “Amorepacific” tickers you’d even be buying.

🎯 Which “Amorepacific” Ticker Are You Actually Buying?

There are three different listed “Amorepacific” securities, and only one — the KRX common share 090430 — is the operating business that analysts value. Getting this wrong is the single most common mistake a foreign investor makes here, so pin it down before anything else.

👑 Why Did Amorepacific Lose Its Crown?

Amorepacific lost the “most valuable K-beauty company” title in August 2025 when APR — a younger, high-margin device-and-skincare brand — passed it in market capitalization. The crossover came at roughly ₩8.35tn for APR versus ~₩7.5tn for Amorepacific (Source: Korea Herald, Aug 2025). By spring 2026 the gap had widened sharply: APR peaked near ₩16tn — roughly double Amorepacific’s — as it was crowned Asia’s most valuable beauty firm (Source: Korea Herald, May 2026). APR has since come off that high. As of the July 28, 2026 close, APR is worth ₩12.49tn against Amorepacific’s ₩6.95tn — still about 1.8× (Source: KRX listed shares × closing price).

The irony: Amorepacific still sells far more. Its FY2025 consolidated revenue was ₩4.25tn (Source: DART FY2025 consolidated), a scale APR is nowhere near. But the market pays for growth and margin trajectory, not size. APR’s asset-light, device-led model grows faster and carries richer margins, so investors handed it a premium multiple. Amorepacific carries the opposite baggage: a legacy China exposure, a bloated brand portfolio it is still pruning, and a decade of underwhelming returns.

We cover the winner of that re-rating in depth in our APR valuation deep-dive, and the broader landscape — brand owners like Amorepacific vs. the ODM manufacturers such as Cosmax that make everyone’s products, vs. new-generation stars like d’Alba Global — in our complete guide to K-beauty stocks.

🇨🇳 Is the China Turnaround Real?

Yes — Greater China returned to operating profit in 2025, but through cost cuts and channel cleanup rather than a demand boom, so it is a repair story, not a growth engine. The region’s sales still declined as Amorepacific deliberately shrank low-quality offline and reseller channels; profitability came from a leaner cost base and a healthier online transaction structure (Source: Amorepacific IR, FY2025 earnings).

The real growth engine has moved west — and the profit number is the one that matters. Overseas revenue rose 15% in 2025, but overseas operating profit doubled, up 102%: the Americas grew revenue ~20% and EMEA ~42%, driven by Laneige’s US traction, Sulwhasoo’s premium push, AESTURA’s US launch and the consolidation of COSRX (Source: Amorepacific Group FY2025 results, Feb 6, 2026; group basis). That geographic pivot — from a China-dependent duty-free and daigou model toward the US and Europe — is the single most important structural change in the Amorepacific story, and it is what the bull case rests on.

💰 Is Amorepacific Stock Expensive?

On its trailing P/E of 29.5× (as of the Jul 28, 2026 close) it looks expensive, but that multiple is distorted by a depressed net-income base — on operating momentum the stock is less stretched than the headline suggests, and consensus sees roughly 40–45% upside. Here is the decode most screens miss.

FY2025 net income fell 58.9% to ₩247.3bn consolidated — ₩235.7bn of that is attributable to the parent’s own shareholders, and that attributable figure is what our 29.5× P/E divides by (Source: DART FY2025, ProfitLossAttributableToOwnersOfParent). Either way it sounds alarming, until you look at 2024: net income that year was ₩601.6bn while operating income was only ₩220.5bn (Source: DART FY2025 & FY2024 consolidated). Net profit exceeding operating profit by that much is the fingerprint of large one-off, non-operating gains — and the filings name the quarter.

Almost all of FY2024’s profit landed in one quarter, and it was not operating profit. In Q2 2024 alone Amorepacific booked net income of ₩530.6bn — versus ₩19.3bn in the same quarter a year earlier — on revenue of ₩904.8bn and operating income of just ₩4.15bn. The bridge is a single line: other non-operating income of ₩424.1bn, against −₩1.7bn a year earlier (Source: DART H1 2024 report, filed Aug 14, 2024). That quarter alone is ~88% of FY2024’s ₩601.6bn net income.

What produced it: Amorepacific had held 38.4% of COSRX since 2021, then paid ₩608bn on April 30, 2024 for the remaining stake, taking it to ~93% and consolidating COSRX from May 2024. Under IFRS, a step acquisition forces the acquirer to re-measure the previously held stake at fair value — the company itself attributed the profit jump to the gain recognised on that equity-method holding (Source: Amorepacific Q2 2024 earnings commentary). It is an accounting event, not cash from selling cosmetics, and it does not repeat.

Strip that base effect out and the real signal is the opposite of decline — operating income rose 52.3% in FY2025, on revenue up 9.5%. Operating margin expanded to 7.9% from 5.7%.

Price, market cap, P/E, dividend and foreign-flow figures: DART (FY2025 filing) and KRX, as of the July 28, 2026 close. Market cap = 58,492,759 listed common shares × ₩118,800; P/E = market cap ÷ FY2025 controlling-interest net income (₩235.7bn) — the same basis we use across the K-beauty stocks guide, so the names are comparable. Screeners dividing by consolidated net income (₩247.3bn) will show 28.1×. USD at ₩1,478.04/$. Consensus target: aggregated sell-side per MarketScreener / Investing.com, late July 2026 (25 analysts) — targets go stale, so treat as a snapshot, not a promise.

So is it cheap? No — a high-20s multiple is not a value stock, and the yield is thin. But the bull framing is defensible: if operating profit keeps compounding as the Americas scale and China stays profitable, the forward multiple compresses meaningfully, and 25 covering analysts lean Buy with an average target 40–45% above the Jul 28 close. The bear framing is equally real (below). This is a genuine judgment call, not a slam dunk — which is exactly why the governance layer matters.

🏛️ Governance & Shareholder Returns

Amorepacific is a textbook Korea Discount case: a founding family controls the operating company through a holding-company tier, and shareholder returns are disciplined rather than generous. This is the layer Western screens rarely read — and where the language-arbitrage edge lives.

Control structure — the numbers Western screens never open. Chairman Suh Kyung-bae sits atop a two-tier structure, and it is tighter than “influence.” At the operating company, Amorepacific Holdings (002790) owns 22,250,869 common shares of 090430 — 38.04% — and Suh himself holds a further 6,228,072 shares, 10.65%, directly. Add the group’s related parties (affiliate executives, the Amorepacific Foundation, Chairman Suh and his family) and the controlling bloc reaches 29,322,200 shares, or 50.13% of the common stock (Source: DART 5% ownership filing, Jul 15, 2026; DART FY2025 annual report). That is an outright majority — no proxy fight can dislodge it.

One tier up, the grip is tighter still. Suh personally holds 43,674,708 common shares of Amorepacific Holdings, 54.97% of its common stock (Source: DART FY2025 annual report, Amorepacific Holdings), and he and related parties together hold 54,086,336 shares — 67.71% (Source: DART 5% ownership filing, Apr 3, 2026). So a family that controls two-thirds of the holding company controls a majority of the listed operating business, despite a large public float and 25.2% foreign ownership at 090430 (Source: Naver/KRX foreign-holdings, as of Jul 28, 2026). That is the essence of the Korea Discount — and it also creates a persistent holding-company NAV discount between 002790 and the sum of its parts.

Shareholder returns — and where they actually land. Amorepacific pays a modest dividend: ₩1,240 per share, a 1.0% yield at the Jul 28, 2026 close (Source: DART FY2025 dividend filing). That is policy, not accident — the company disclosed a target of paying out ~35% of consolidated net income for FY2023–2025, capped at 40% of annual free cash flow. DART shows the reported consolidated payout ratio at 34.9% (FY2023), 13.1% (FY2024) and 36.3% (FY2025) (Source: DART dividend disclosures). The FY2024 outlier is the same COSRX one-off decoded above: the denominator was inflated, so the ratio collapsed — which is why the company’s own Value-Up implementation disclosure reports an adjusted payout of 35% for FY2023 and FY2024, i.e. 100% of target (Source: Amorepacific Corporate Value-Up plan, DART, Nov 6, 2025). The policy held; the accounting moved.

The generosity sits one tier up, and that is the real finding. The holding company (002790) committed in November 2024 to pay out 50–75% of separate-basis net profit, and Korean coverage of its Value-Up scorecard puts FY2023 and FY2024 at the top of that range — a 75% payout ratio (Source: Hankyung Business corporate-governance review, Jan 2026; separate-basis, so it is not comparable to DART’s consolidated figures of 21.0% / 12.7%). It also went further than the operating company ever has: on February 13, 2025 the holdco cancelled 3,000,000 of its own common shares, roughly ₩68.9bn worth, and it has filed further cancellation decisions since (Feb 6, 2026 and Mar 9, 2026) (Source: DART FY2025 annual report total-shares note; DART filing index for Amorepacific Holdings). Cancellation — not just buying back — is the shareholder return Korea’s Value-Up program is really asking for, and this is the one place in the group where it is actually happening. Note the side effect: with the share count shrinking, the family’s reported stake in the holdco rose from 63.34% (Jan 2025) to 67.71% (Apr 2026) while its share count barely moved (Source: DART 5% ownership filings). Cancellation returns capital and tightens control at the same time.

That asymmetry is the point: returns are concentrated at the tier the family owns two-thirds of, not at the operating company most foreign investors actually buy. Both entities have published Corporate Value-Up disclosures, yet 090430’s payout stays at the 35% line with no cancellation programme of its own. For context on why the programme exists and what “good” looks like, see our Value-Up program guide.

Governance risk to watch. Succession is already visible in the filings rather than the rumour mill: Chairman Suh’s daughters hold holding-company stock directly — Suh Min-jung with 2,412,710 common shares (3.04%) and Suh Ho-jung with 584,048 common (0.74%) plus 1,728,000 preferred shares (12.77% of that class) (Source: DART FY2025 annual report, Amorepacific Holdings). Any reshuffling of those stakes can move both 002790 and 090430, and Korea’s inheritance-tax regime has historically pushed founding families toward structures that suppress the share price rather than lift it. The upside case for closing the discount is a more shareholder-friendly turn at the operating company — a higher payout, buyback-and-cancel, a cleaner structure. Until that arrives, the discount is rational, not a mispricing.

📚 Lingo Check

🎯 Why It Matters for K-Export Stars

Amorepacific is the purest test of the K-Export Stars thesis: a Korean brand exporting culture and margin to the world, priced by a market that still applies a governance discount. The interesting money is not in re-reporting the earnings — the wires did that in February. It is in decoding what a Western screen gets wrong: that the scary net-income “drop” is a base effect, that the AMRWF ticker isn’t the share you think it is, and that the holding-company structure explains the cheapness better than any DCF. That is the language-arbitrage edge — reading the Korean filing and ownership chain that most global investors never open.

Disclaimer: This article is for informational and educational purposes only and is not investment advice, a recommendation, or a solicitation to buy or sell any security. Figures are drawn from official filings (DART), KRX/Naver market data and company IR as of the dates cited, and may be superseded by later data or events. Prices and analyst targets change; verify live quotes before acting. Do your own research and consult a licensed financial adviser before making any investment decision.